Therapeutic agent for ocular disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9561210
APP PUB NO 20160008317A1
SERIAL NO

14776048

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The purpose of this invention is to provide a compound for preventing or treating an ocular disease and a pharmaceutical composition comprising the same. This invention provides a pharmaceutical composition comprising a compound as defined by the formula (I′) or a pharmaceutically acceptable salt thereof. The pharmaceutical composition is useful for preventing or treating an ocular disease such as retinochoroidal degeneration.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASKAT INC4-37-2 HIROJIHONMACHI SHOWA-KU NAGOYA 466-0841

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hara, Hideaki Gifu, JP 69 695
Koizumi, Shinichi Aichi, JP 33 166
Okumura, Takako Aichi, JP 18 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00